DrugDevCovid19

Tracking the relevant researches of CADD drug development against COVID-19

Resveratrol

ID MW HBD HBA
445154  228.233
RB NOA Rings logP
5323.13

Function

DrugBank ID:

DB02709


Description:

Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as cis-(Z) and trans-(E) isomers. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet irradiation. In a 2004 issue of Science, Dr. Sinclair of Harvard University said resveratrol is not an easy molecule to protect from oxidation. It has been claimed that it is readily degraded by exposure to light, heat, and oxygen. However, studies find that Trans-resveratrol undergoes negligible oxidation in normal atmosphere at room temperature. [DrugBank]

Targets:

Ribosyldihydronicotinamide dehydrogenase [quinone] (Humans); Casein kinase II subunit alpha (Humans); Prostaglandin G/H synthase 1 (Humans); Prostaglandin G/H synthase 2 (Humans); Arachidonate 15-lipoxygenase (Humans); Arachidonate 5-lipoxygenase (Humans); Aryl hydrocarbon receptor (Humans); Phosphatidylinositol 4-kinase type 2-beta (Humans); Integrin alpha-5 (Humans); Integrin beta-3 (Humans); Amyloid beta A4 protein (Humans); Alpha-synuclein (Humans); NAD-dependent protein deacetylase sirtuin-1 (Humans); Estrogen receptor alpha (Humans); Melatonin receptor type 1A (Humans); Melatonin receptor type 1B (Humans); C-type lectin domain family 14 member A (Humans); Nuclear receptor subfamily 1 group I member 2 (Humans); Nuclear receptor subfamily 1 group I member 3 (Humans); Solute carrier family 2, facilitated glucose transporter member 1 (Humans); Carbonyl reductase [NADPH] 1 (Humans); Peroxisome proliferator-activated receptor alpha (Humans); Peroxisome proliferator-activated receptor gamma (Humans); RAC-alpha serine/threonine-protein kinase (Humans); Far upstream element-binding protein 2 (Humans); Tyrosine--tRNA ligase, cytoplasmic (Humans) [DrugBank]

Pharmacodynamics:

Resveratrol, a phytoalexin, has been found to inhibit herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) replication in a dose-dependent, reversible manner, although this is only one of its many pharmaceutical properties. In some countries where there is higher consumption of red wine, there appears to be a lower incidence of heart disease. Other benefits of resveratrol include its anti-inflammatory and antioxidant effects. In preclinical studies, Resveratrol has been found to have potential anticancer properties. [DrugBank]

Structures

SMILES:

Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1

2D structures:  

3D structures:  

Docking in target protein

Receptor: S-glycoprotein

Docking Site: PPI surface (ACE2:S-glycoprotein)

Ligand: Resveratrol

Vina score: -5.7

Off-target analysis based on ligand similarity (Homo sapiens)

Step 1 - Target prediction for Resveratrol: SwissTargetPrediction

Tips: Click on the link to jump to the 'SwissTargetPrediction' webserver. Select the species of 'Homo sapiens', and then paste the SMILES of Resveratrol in the SMILES input box.

Step 2 - Blind docking for Resveratrol: CB-Dock

Tips: Click on the link to jump to the 'CB-Dock' webserver. Upload the structure file of target predicted by 'SwissTargetPrediction' and the 2D/3D structure file of Resveratrol to perform blind docking.